These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29929770)

  • 21. The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels.
    Neumann I; Brignardello-Petersen R; Wiercioch W; Carrasco-Labra A; Cuello C; Akl E; Mustafa RA; Al-Hazzani W; Etxeandia-Ikobaltzeta I; Rojas MX; Falavigna M; Santesso N; Brozek J; Iorio A; Alonso-Coello P; Schünemann HJ
    Implement Sci; 2016 Jul; 11():93. PubMed ID: 27417219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The GRADE approach, Part 2: Evidence to decision frameworksoutlining decision-making in health.
    Quilodrán C; Kirmayr M; Valente B; Pérez-Bracchiglione J; Garegnani L; Franco JVA
    Medwave; 2021 May; 21(4):e8182. PubMed ID: 34086664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing Evidence to Decision Frameworks and an Interactive Evidence to Decision Tool for Making and Using Decisions and Recommendations in Health Care.
    Rosenbaum SE; Moberg J; Glenton C; Schünemann HJ; Lewin S; Akl E; Mustafa RA; Morelli A; Vogel JP; Alonso-Coello P; Rada G; Vásquez J; Parmelli E; Gülmezoglu AM; Flottorp SA; Oxman AD
    Glob Chall; 2018 Sep; 2(9):1700081. PubMed ID: 31565348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decisions to Start, Strengthen, and Sustain Food Fortification Programs: An Application of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) Evidence to Decision (EtD) Framework in Nigeria.
    Friesen VM; Mbuya MNN; Wieringa FT; Nelson CN; Ojo M; Neufeld LM
    Curr Dev Nutr; 2022 Mar; 6(3):nzac010. PubMed ID: 35261958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardized wording to improve efficiency and clarity of GRADE EtD frameworks in health guidelines.
    Piggott T; Baldeh T; Dietl B; Wiercoch W; Nieuwlaat R; Santesso N; Coello PA; Schünemann HJ
    J Clin Epidemiol; 2022 Jun; 146():106-122. PubMed ID: 35041970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using GRADE Evidence to Decision frameworks to support the process of health policy-making: an example application regarding taxation of sugar-sweetened beverages.
    Stadelmaier J; Rehfuess EA; Forberger S; Eisele-Metzger A; Nagavci B; Schünemann HJ; Meerpohl JJ; Schwingshackl L
    Eur J Public Health; 2022 Nov; 32(Suppl 4):iv92-iv100. PubMed ID: 36444109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations.
    Meneses-Echavez JF; Bidonde J; Montesinos-Guevara C; Amer YS; Loaiza-Betancur AF; Tellez Tinjaca LA; Fraile Navarro D; Poklepović Peričić T; Tokalić R; Bala MM; Storman D; Swierz M; Zając J; Flórez ID; Schünemann H; Flottorp S; Alonso-Coello P
    J Clin Epidemiol; 2023 Oct; 162():38-46. PubMed ID: 37517506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qualitative Evidence Synthesis (QES) for Guidelines: Paper 2 - Using qualitative evidence synthesis findings to inform evidence-to-decision frameworks and recommendations.
    Lewin S; Glenton C; Lawrie TA; Downe S; Finlayson KW; Rosenbaum S; Barreix M; Tunçalp Ö
    Health Res Policy Syst; 2019 Aug; 17(1):75. PubMed ID: 31391119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using GRADE evidence to decision frameworks to choose from multiple interventions.
    Piggott T; Brozek J; Nowak A; Dietl H; Dietl B; Saz-Parkinson Z; Mirzayev F; González-Angulo L; Yepes-Nuñez JJ; Mustafa RA; Leontiadis GI; Brignardello-Petersen R; Alonso-Coello P; Schünemann HJ
    J Clin Epidemiol; 2021 Feb; 130():117-124. PubMed ID: 33127374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Simulation Modeling to Inform Decision Making for Health Care Systems and Policy in Colorectal Cancer Screening: Protocol for a Systematic Review.
    Smith H; Varshoei P; Boushey R; Kuziemsky C
    JMIR Res Protoc; 2020 May; 9(5):e16103. PubMed ID: 32401223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Integrative assessment of evidence in healthcare: the GRADE system].
    Schünemann H
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(5):261-8. PubMed ID: 19645339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating how the GRADE Evidence to Decision (EtD) framework is used in Clinical Guidelines: a scoping review protocol.
    Murray R; Sharp M; Razidan A; Hibbitts B; Ryan M; Mahtani K; Lynch R; Smith S; O'Neill M; Schünemann H; Alonso-Coello P; Munn Z; Clyne B
    HRB Open Res; 2023; 6():50. PubMed ID: 38779426
    [No Abstract]   [Full Text] [Related]  

  • 34. Decision-making frameworks and considerations for informing coverage decisions for healthcare interventions: a critical interpretive synthesis.
    Morgan RL; Kelley L; Guyatt GH; Johnson A; Lavis JN
    J Clin Epidemiol; 2018 Feb; 94():143-150. PubMed ID: 28988959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GRADE: Assessing the quality of evidence in environmental and occupational health.
    Morgan RL; Thayer KA; Bero L; Bruce N; Falck-Ytter Y; Ghersi D; Guyatt G; Hooijmans C; Langendam M; Mandrioli D; Mustafa RA; Rehfuess EA; Rooney AA; Shea B; Silbergeld EK; Sutton P; Wolfe MS; Woodruff TJ; Verbeek JH; Holloway AC; Santesso N; Schünemann HJ
    Environ Int; 2016; 92-93():611-6. PubMed ID: 26827182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transparency in the body of evidence in medicine: developments of the GRADE method in the past ten years].
    Langendam MW; Kuijpers T; Heus P; Verstijnen I; Vernooij R; Boluyt N; Hooft L
    Ned Tijdschr Geneeskd; 2022 Oct; 166():. PubMed ID: 36300451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations.
    Xie F; Shemilt I; Vale L; Ruiz F; Drummond MF; Lord J; Herrmann KH; Rojas MX; Zhang Y; Canelo-Aybar C; Alonso-Coello P; Shamliyan T; Schünemann HJ
    J Clin Epidemiol; 2023 Oct; 162():135-144. PubMed ID: 37597696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.
    Zhang Y; Coello PA; Brożek J; Wiercioch W; Etxeandia-Ikobaltzeta I; Akl EA; Meerpohl JJ; Alhazzani W; Carrasco-Labra A; Morgan RL; Mustafa RA; Riva JJ; Moore A; Yepes-Nuñez JJ; Cuello-Garcia C; AlRayees Z; Manja V; Falavigna M; Neumann I; Brignardello-Petersen R; Santesso N; Rochwerg B; Darzi A; Rojas MX; Adi Y; Bollig C; Waziry R; Schünemann HJ
    Health Qual Life Outcomes; 2017 May; 15(1):52. PubMed ID: 28460638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.